OpenURL Connection Search

Select item for more details and to access through your institution.

STRUCTURAL BEHAVIOR OF VOIDED NORMAL AND HIGH STRENGTH REINFORCED CONCRETE SLABS.
Published in:
Kufa Journal of Engineering, 2019, v. 10, n. 2, p. 1, doi. 10.30572/2018/kje/100201
By:
- Nimnim, Hayder T.;
- Alabdeen, Zahraa M. J. Zain
Publication type:
Article
Prostate cancer: some interesting facts.
Published in:
International Journal of Clinical Practice, 2011, v. 65, n. 4, p. 514, doi. 10.1111/j.1742-1241.2010.02609.x
By:
- Das, S.;
- Zain, J. M.
Publication type:
Article
Mogamulizumab efficacy is underscored by its associated rash that mimics cutaneous T‐cell lymphoma: a retrospective single‐centre case series*.
Published in:
British Journal of Dermatology, 2022, v. 186, n. 1, p. 153, doi. 10.1111/bjd.20708
By:
- Trum, N.A.;
- Zain, J.;
- Martinez, X.U.;
- Parekh, V.;
- Afkhami, M.;
- Abdulla, F.;
- Carson, K.R.;
- Rosen, S.T.;
- Bennett, C.L.;
- Querfeld, C.
Publication type:
Article
Reduced-intensity allogeneic hematopoietic cell transplantation using fludarabine-melphalan conditioning for treatment of mature T-cell lymphomas.
Published in:
Bone Marrow Transplantation, 2012, v. 47, n. 1, p. 65, doi. 10.1038/bmt.2011.16
By:
- Delioukina, M;
- Zain, J;
- Palmer, J M;
- Tsai, N;
- Thomas, S;
- Forman, S
Publication type:
Article
Thymoglobulin, CYA and mycophenolate mofetil as GVHD prophylaxis for reduced-intensity unrelated donor hematopoietic cell transplantation: beneficial effect seen on chronic GVHD.
Published in:
2010
By:
- Rodriguez, R.;
- Nademanee, A.;
- Palmer, J. M.;
- Parker, P.;
- Nakamura, R.;
- Snyder, D.;
- Pullarkat, V.;
- Zain, J.;
- Smith, E.;
- Sahebi, F.;
- Patane, K.;
- Senitzer, D.;
- Chang, K.;
- Forman, S. J.
Publication type:
Letter
Biomarker for cardiorenal syndrome risk in patients with liver cirrhosis and type 2 diabetes in Saudi Arabia.
Published in:
Saudi Medical Journal, 2024, v. 45, n. 7, p. 675, doi. 10.15537/smj.2024.45.7.20240156
By:
- Mohammedsaeed, Walaa;
- Alghamdi, Zain J.
Publication type:
Article
Autoimmune diseases and their prevalence in Saudi Arabian patients with type 1 diabetes mellitus.
Published in:
Saudi Medical Journal, 2023, v. 44, n. 8, p. 751, doi. 10.15537/smj.2023.44.8.20230240
By:
- Mohammedsaeed, Walaa M.;
- Alghamdi, Zain J.
Publication type:
Article
Brentuximab vedotin does not cause clinically relevant QTc interval prolongation in patients with CD30-positive hematologic malignancies.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 1, p. 241, doi. 10.1007/s00280-013-2192-z
By:
- Han, T.;
- Chen, R.;
- Advani, R.;
- Berryman, R.;
- Smith, S.;
- Forero-Torres, A.;
- Rosenblatt, J.;
- Smith, M.;
- Zain, J.;
- Hunder, N.;
- Engert, A.
Publication type:
Article
A phase 1 trial dose-escalation study of tipifarnib on a week-on, week-off schedule in relapsed, refractory or high-risk myeloid leukemia.
Published in:
2011
By:
- Kirschbaum, M H;
- Synold, T;
- Stein, A S;
- Tuscano, J;
- Zain, J M;
- Popplewell, L;
- Karanes, C;
- O'Donnell, M R;
- Pulone, B;
- Rincon, A;
- Wright, J;
- Frankel, P;
- Forman, S J;
- Newman, E M
Publication type:
journal article
Encouraging complete responses (CRs) with CDK9 inhibitor AZD4573 in patients (pts) with relapsed/refractory (r/r) peripheral T‐cell Lymphoma (PTCL): Early trial analysis.
Published in:
Hematological Oncology, 2023, v. 41, p. 568, doi. 10.1002/hon.3164_425
By:
- Zinzani, P. L.;
- Feldman, T.;
- Collins, G.;
- Zain, J.;
- Khot, A.;
- Kim, J. S.;
- Morschhauser, F.;
- Kim, T. M.;
- Roderick, J.;
- Yoon, J. L.;
- Sharma, S.;
- Saeh, J.;
- Dai, J.;
- Reyes, R.;
- Olsson, R. F.;
- Shortt, J.
Publication type:
Article
Duvelisib in patients with relapsed/refractory peripheral T‐cell lymphoma from the phase 2 PRIMO Trial Expansion Phase: outcomes by baseline histology.
Published in:
Hematological Oncology, 2023, v. 41, p. 499, doi. 10.1002/hon.3164_367
By:
- Mehta‐Shah, N.;
- Jacobsen, E. D.;
- Zinzani, P. L.;
- Zain, J.;
- Mead, M.;
- Casulo, C.;
- Gritti, G.;
- Pinter‐Brown, L.;
- Izutsu, K.;
- Waters, S.;
- Brammer, J. E.;
- Pro, B.;
- Horwitz, S. M.
Publication type:
Article
MULTI‐CENTER PHASE II STUDY OF ROMIDEPSIN PLUS LENALIDOMIDE FOR PATIENTS WITH PREVIOUSLY UNTREATED PERIPHERAL T‐CELL LYMPHOMA (PTCL)
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.55_2879
By:
- Ruan, J.;
- Zain, J. M;
- Palmer, B.;
- Jovanovic, B. Borko;
- Mi, X.;
- Swaroop, A.;
- Winter, J.;
- Gordon, L. I;
- Karmali, R.;
- Pro, B.
Publication type:
Article
PHASE 1 RESULTS OF ANTI‐PD‐LIGAND 1 (DURVALUMAB) & LENALIDOMIDE IN PATIENTS WITH CUTANEOUS T CELL LYMPHOMA AND CORRELATION WITH GENE EXPRESSION PROFILE.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.125_2880
By:
- Querfeld, C. S.;
- Tsai, N.‐C.;
- Palmer, J.;
- Martinez, X.;
- Abdulla, F.;
- Wu, X.;
- Rosen, S. T.;
- Zain, J.
Publication type:
Article
PHASE I/II STUDY OF CHOEP PLUS LENALIDOMIDE AS INITIAL THERAPY FOR PATIENTS WITH STAGE II‐IV PERIPHERAL T‐CELL LYMPHOMA: PHASE II RESULTS.
Published in:
Hematological Oncology, 2019, v. 37, p. 280, doi. 10.1002/hon.91_2630
By:
- Lunning, M.;
- Horwitz, S.;
- Advani, R.;
- Vose, J.;
- Lee, H.;
- Mehta‐Shah, N.;
- Zain, J.;
- Haverkos, B.;
- Lechowicz, M.;
- Moskowitz, A.;
- Heires, P.;
- Lyden, L.;
- Ansell, S.
Publication type:
Article
PHASE 1/2 TRIAL OF ANTI‐PD‐LIGAND 1 (DURVALUMAB) +/‐ LENALIDOMIDE IN PATIENTS WITH CUTANEOUS T CELL LYMPHOMA: PRELIMINARY RESULTS OF PHASE 1 AND CORRELATIVE STUDIES.
Published in:
Hematological Oncology, 2019, v. 37, p. 519, doi. 10.1002/hon.205_2631
By:
- Querfeld, C.;
- Zain, J.;
- Jovanovic‐Talisman, T.;
- Wakefield, D.L.;
- Kil, S.;
- Estephan, R.;
- Young, P.;
- Sanchez, J.;
- Martinez, X.;
- Stiller, T.;
- Palmer, J.;
- Rosen, S.T.
Publication type:
Article
MDS AS A CAUSE FOR PROLONGED HEMATOLOGIC TOXICITY AFTER TREATMENT WITH CD19 TARGETED CAR‐T CELL THERAPY IN PATIENTS WITH RELAPSED REFRACTORY LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 507, doi. 10.1002/hon.190_2631
By:
- Shouse, G.P.;
- Xue, T.;
- Herrera, A.;
- Siddiqi, T.;
- Zain, J.;
- Popplewell, L.;
- Forman, S.;
- Budde, E.
Publication type:
Article
PET‐ADAPTED NIVOLUMAB +/‐ ICE AS INITIAL SALVAGE THERAPY IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 293, doi. 10.1002/hon.102_2630
By:
- Herrera, A.F.;
- Chen, R.;
- Palmer, J.;
- Tsai, N.;
- McBride, K.;
- Song, J.;
- Mei, M.;
- Zain, J.;
- Nikolaenko, L.;
- Popplewell, L.;
- Nademanee, A.;
- Rosen, S.;
- Kwak, L.;
- Lee, H.;
- Forman, S.
Publication type:
Article
PHASE I/II STUDY OF CHOEP PLUS LENALIDOMIDE AS INITIAL THERAPY FOR PATIENTS WITH STAGE II‐IV PERIPHERAL T‐CELL LYMPHOMA: PHASE II RESULTS.
Published in:
Hematological Oncology, 2019, v. 37, p. 280, doi. 10.1002/hon.91_2630
By:
- Lunning, M.;
- Horwitz, S.;
- Advani, R.;
- Vose, J.;
- Lee, H.;
- Mehta‐Shah, N.;
- Zain, J.;
- Haverkos, B.;
- Lechowicz, M.;
- Moskowitz, A.;
- Heires, P.;
- Lyden, L.;
- Ansell, S.
Publication type:
Article
PHASE 1/2 TRIAL OF ANTI‐PD‐LIGAND 1 (DURVALUMAB) +/‐ LENALIDOMIDE IN PATIENTS WITH CUTANEOUS T CELL LYMPHOMA: PRELIMINARY RESULTS OF PHASE 1 AND CORRELATIVE STUDIES.
Published in:
Hematological Oncology, 2019, v. 37, p. 519, doi. 10.1002/hon.205_2631
By:
- Querfeld, C.;
- Zain, J.;
- Jovanovic‐Talisman, T.;
- Wakefield, D.L.;
- Kil, S.;
- Estephan, R.;
- Young, P.;
- Sanchez, J.;
- Martinez, X.;
- Stiller, T.;
- Palmer, J.;
- Rosen, S.T.
Publication type:
Article
MDS AS A CAUSE FOR PROLONGED HEMATOLOGIC TOXICITY AFTER TREATMENT WITH CD19 TARGETED CAR‐T CELL THERAPY IN PATIENTS WITH RELAPSED REFRACTORY LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 507, doi. 10.1002/hon.190_2631
By:
- Shouse, G.P.;
- Xue, T.;
- Herrera, A.;
- Siddiqi, T.;
- Zain, J.;
- Popplewell, L.;
- Forman, S.;
- Budde, E.
Publication type:
Article
PET‐ADAPTED NIVOLUMAB +/‐ ICE AS INITIAL SALVAGE THERAPY IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 293, doi. 10.1002/hon.102_2630
By:
- Herrera, A.F.;
- Chen, R.;
- Palmer, J.;
- Tsai, N.;
- McBride, K.;
- Song, J.;
- Mei, M.;
- Zain, J.;
- Nikolaenko, L.;
- Popplewell, L.;
- Nademanee, A.;
- Rosen, S.;
- Kwak, L.;
- Lee, H.;
- Forman, S.
Publication type:
Article
PHASE I/II STUDY OF CHOEP PLUS LENALIDOMIDE AS INITIAL THERAPY FOR PATIENTS WITH STAGE II-IV PERIPHERAL T-CELL NON-HODGKIN LYMPHOMA: PHASE I RESULTS FROM THE T-CELL CONSORTIUM.
Published in:
Hematological Oncology, 2017, v. 35, p. 411, doi. 10.1002/hon.2439_190
By:
- Lunning, M.;
- Horwitz, S.;
- Mehta ‐ Shah, N.;
- Moskowitz, A.;
- Advani, R.;
- Beaven, A.;
- Haverkos, B.;
- Lechowicz, M.;
- Oki, Y.;
- Zain, J.;
- Ansell, S.
Publication type:
Article
DUAL PI3K δ/γ INHIBITOR RP6530 IN PATIENTS WITH RELAPSED/REFRACTORY T-CELL LYMPHOMA: DOSE ESCALATION FINDINGS.
Published in:
Hematological Oncology, 2017, v. 35, p. 412, doi. 10.1002/hon.2439_191
By:
- Oki, Y.;
- Zain, J.;
- Haverkos, B.;
- Barde, P.;
- Penmetsa, K.;
- Huen, A.
Publication type:
Article
Multiple Intracranial Hydatidosis.
Published in:
Acta Neurochirurgica, 2002, v. 144, n. 11, p. 1179, doi. 10.1007/s00701-002-0987-5
By:
- Al Zain, T. J.;
- Al-Witry, S. H.;
- Khalili, H. M.;
- Aboud, S. H.;
- Al Zain Jr, F. T.
Publication type:
Article
Monocytic leukemia cutis diagnosed simultaneously with refractory anemia with monocytosis: A case report.
Published in:
American Journal of Hematology, 2001, v. 66, n. 2, p. 120, doi. 10.1002/1096-8652(200102)66:2<120::AID-AJH1027>3.0.CO;2-V
By:
- Yavorkovsky, L.L.;
- Zain, J.;
- Wu, C.D.;
- Trivelli, L.;
- Cook, P.
Publication type:
Article
Measurement of the Reactivity Coefficients and Neutron Flux of the SLOWPOKE-2 Reactor Using OpenMC.
Published in:
International Journal on Engineering Applications, 2023, v. 11, n. 4, p. 270, doi. 10.15866/irea.v11i4.23349
By:
- El Mtili, A.;
- El Hajjaji, O.;
- El Bardouni, T.;
- El Hlaibi, S. El Maliki;
- El Yaakoubi, H.;
- Al Zain, J.
Publication type:
Article

Found: 26